Cholesterol lowering supplement

a cholesterol-lowering supplement and cholesterol-lowering technology, applied in the field of cholesterol-lowering supplements, can solve the problems of increased faecal excretion of bile acids, critical side effects of statin use, and lack of potent cholesterol absorption-inhibiting components in herbal combinations, so as to prevent elevated blood serum cholesterol levels, and reduce blood serum cholesterol levels

Inactive Publication Date: 2005-05-12
NUTRICIA
View PDF2 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0021] The combination composition disclosed here fulfils the need for cholesterol-reducing combinations having plant-derived active components. The composition according to the invention can therefore be administered for a longer period, thus making it suitable for use in compositions for reduction of blood serum cholesterol levels or prevention of elevated blood serum cholesterol levels. The invention provides a balanced composition for...

Problems solved by technology

Soluble fibres are able to interact with bile acids, which results in an increased faecal excretion of bile acids.
Further described is the main disadvantage of the above composition i.e. the use of statins, and the critical side effects related with the use of statins.
However, the herbal combination lacks a potent cholesterol absorption-inhibiting component.
Combination compositions including cholesterol absorption inhibitors and cholesterol synthesis inhibitors useful for reduction of blood serum cholesterol levels known in the art a...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

Capsule Composition I

[0051] A capsule comprising:

[0052] 500 mg phytosterol mixture; including about brassicasterol (6%), campesterol (30%), stigmasterol (22%), sitosterol (58%).

[0053] 250 mg concentrated Radix Polygoni multiflora water extract with concentration ratio of 16:1 (obtainable form P.L. Thomas & Co.. Inc, having address Morristown, N.J. 07980)

[0054] 200 mg Flos Chrysanthemi extract (obtainable form MTC Nutricions, Inc, Whitestone, N.Y. 11357).

[0055] Three capsules per day is the recommended treatment.

example 2

Capsule Composition II

[0056] A capsule comprising:

[0057] 500 mg phytosterol mixture, including about brassicasterol (6%), campesterol (30%), stigmasterol (22%), sitosterol (58%).

[0058] 250 mg Radix Polygoni multiflora extract

[0059] 200 mg Flos Chrysanthemi extract

[0060] 400 mg lecithin

[0061] 60 mg eicosapentaenoic acid

[0062] 60 mg docosahexaenoic acid.

[0063] Three capsules per day is the recommended treatment.

example 3

Capsule Composition III

[0064] The capsule described in example 1, further comprising:

[0065] 1000 mg soybean oil

[0066] 150 mg lauric acid and monoolein.

[0067] Three capsules per day is the recommended treatment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Percent by massaaaaaaaaaa
Massaaaaaaaaaa
Massaaaaaaaaaa
Login to view more

Abstract

The invention provides a composition and a method for lowering blood serum cholesterol levels or for preventing elevated blood serum cholesterol levels, as well as a suitable composition comprising (a) one or more phytosterols and/or phytostanols capable of reducing cholesterol absorption in the intestine and/or one or more soluble fibres capable of inhibiting ileal bile acid absorption, (b) a composition capable of inhibiting cholesterol biosynthesis, and (c) a composition capable of increasing cholesterol metabolism, wherein at least one of compositions (b) and (c) is preferably derived from plants.

Description

BACKGROUND OF THE INVENTION [0001] Cardiovascular diseases (CVD) are the major cause of death and disability in industrialised countries, despite recent declines in CVD mortality rates. They account for more deaths annually than any other disease, including all forms of cancer combinedi. In the USA more than 1 million heart attacks occur each year and more than half a million people still die as a result. This enormous toll has focused attention on the possible prevention of CVD by various means, especially through lowering of plasma cholesterol levels. It is well established now that elevated total cholesterol, and in particular low-density lipoprotein (LDL) cholesterol, in plasma plays an important role in the development of atherosclerosisii. Clinical trials have demonstrated clearly that decreasing cholesterol concentrations in plasma can contribute to primary and secondary prevention of coronary events and mortality.iii Some studies have estimated a 2% reduction in risk of a co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A23L1/30A23L1/308A61K36/236A61K36/254A61K36/282A61K36/287A61K36/481A61K36/505A61K36/537A61K36/704A61K36/734A61K36/88A61K36/884A61K36/8969A61K36/9066
CPCA61K36/884A23L1/3004A23L1/308A23V2002/00A61K36/236A61K36/254A61K36/282A61K36/287A61K36/481A61K36/505A61K36/537A61K36/9066A61K36/8969A23L1/3002A61K36/88A61K36/734A61K36/704A61K2300/00A23V2250/2136A23V2250/21A23V2250/187A23V2250/1868A23V2250/1842A23V2250/712A23V2250/5072A23V2250/506A23V2250/5028A23V2250/507A23V2250/5034A23L33/105A23L33/11A23L33/21A61P3/06A61P9/10
Inventor CHEN, QIDE BONT, HENDRICUS BARTHOLOMEUS ANDREASVAN DER ZEE, LUUTSCHELANSINK, MIRIANVAN NORREN, KLASKEVAN DER BURGT, LEONTINE MARTINA JOHANNA
Owner NUTRICIA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products